Ever since the introduction of MBCP™ Technology 20 years ago, Biomatlante has been at the forefront of development of new synthetic matrices for bone regeneration to best suit the needs of surgeons and patients alike.
Partnerships with research institutes and universities have enabled us to maintain our lead in developing innovative materials to meet today’s exacting requirements.
Patient safety will always be our top priority. We constantly strive to provide products with the highest safety profile. Surgeons in over 50 countries have entrusted us with the welfare of over 1,000,000 patients.